Banzel is a medication that is primarily used to treat seizures in individuals with Lennox-Gastaut syndrome (LGS). It contains the active ingredient rufinamide, which helps to control seizures by stabilizing abnormal electrical activity in the brain.
Lennox-Gastaut syndrome is a severe form of epilepsy that typically begins during early childhood. It is characterized by multiple types of seizures, cognitive impairment, and developmental delays. Banzel is often prescribed as an adjunctive therapy, meaning it is used in addition to other epilepsy medications, to help reduce the frequency and severity of seizures in individuals with LGS.




